Company Filing History:
Years Active: 2021
Title: **Michaela Grass: Innovator in Pharmaceutical Formulations**
Introduction
Michaela Grass, an accomplished inventor based in Rheinfelden, Germany, has made a significant impact in the realm of pharmaceuticals with her innovative work. With a focus on the development of peptidomimetic macrocycles, her research has important implications for treating various diseases and disorders.
Latest Patents
Michaela holds one patent titled "Peptidomimetic Macrocycles and Formulations Thereof." This patent presents aqueous pharmaceutical formulations designed for parenteral administration. The formulations include a peptidomimetic macrocycle or a pharmaceutically acceptable salt that binds to MDM2 and/or MDMX proteins. Additionally, the patent outlines methods for treating a range of diseases utilizing these formulations.
Career Highlights
Currently, Michaela is a key member of Aileron Therapeutics, Inc., a company that specializes in the development of novel therapies using innovative technologies. Her expertise and creativity contribute significantly to the advancement of drug development processes within the organization.
Collaborations
Throughout her career, Michaela has collaborated with notable individuals in her field. Among her coworkers are David Allen Annis and Krzysztof Darlak, both of whom bring a wealth of knowledge and experience to their joint projects at Aileron Therapeutics, Inc.
Conclusion
Michaela Grass exemplifies the spirit of innovation in the pharmaceutical industry. With her pioneering patent and collaborative efforts at Aileron Therapeutics, Inc., she is poised to make lasting contributions to the field of medicine. Her work is a testament to the power of creativity and scientific inquiry in addressing pressing health challenges.